Skip to main content
Trending storyContinuously updated

bit.bio closes $25M Series D to scale human cell models

1 reports1 report sources3 hours agoUpdate

Get up to speed on this story

AI Summary

Human cell programming company bit.bio closed a $25 million Series D round. The company says the funding will go toward expanding its portfolio of human cell models and widening access to its technology for pharmaceutical companies, biotech businesses and research organizations.

AI-generated from reports · 2 hours agoUpdate

Latest updatesNov 4 17:01
bit.bio raises $25M Series D to scale human cell models

Report timeline

Follow the reports to understand different sides of the story.

Nov 4
  1. Tech.euTop Deals
    bit.bio raises $25M Series D to scale human cell models

    Human cell programming company bit.bio closed a $25 million Series D.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing